* The role of the US in global efforts to address pollutants that are broadly dispersed across national borders, such as greenhouse gasses, persistent organic pollutants, ozone, etc...; * How they view a president's ability to influence national science policy in a way that will persist beyond their term (s), as would be necessary for example to address global climate change or enhancement of science education nationwide; * Their perspective on the relative roles that scientific knowledge, ethics, economics, and faith should play in resolving debates
over embryonic stem cell research, evolution education, human population growth, etc... * What specific steps they would take to prevent the introduction of political or economic bias in the dissemination and use of scientific knowledge; * (and many more...)
They also touched off the most serious moral and ethical debate so far
over both embryonic stem cell research and human cloning.
In his January 2008 State of the Union address, President George W. Bush claimed that research by James Thomson of the University of Wisconsin and Shinya Yamanaka of the University of Kyoto in Japan would finally end the morally and politically nettlesome debate
over embryonic stem cell research.
Take the debate
over embryonic stem cell research.
He gives the example of the debates
over embryonic stem cell research.
Not exact matches
In the time of all this fighting we've had [
over embryonic stem -
cell research]-- which did slow down this [adult
stem -
cell]
research — in the last year we've advanced ten years.»
Second problem: One group that does not know the debate is
over is the group of pro «
embryonic stem -
cell research advocates, whose name is Legion.
«We thought the fight was
over,» Tom Harkin (D — Iowa) and chairman of the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies said at a hearing on
embryonic stem cell research on Thursday.
But just how close adult and reprogrammed
stem cells can come to matching the capabilities of
embryonic stem cells has become a contentious question in the debate
over whether the federal government should continue funding
research on
embryonic lines.
Now
research describing a simple way of producing
embryonic - like
stem cells is being investigated
over «inconsistencies».
«It's an exciting development, and we await the outcome
over the next year to see how well these
cells integrate, and if there are any potential adverse reactions,» says Mike Cheetham of the Institute of Ophthalmology at University College London, one site where
research is under way into a human
embryonic stem -
cell treatment for AMD.
In late 2004, California voters approved Proposition 71, allocating $ 3 billion
over 10 years, making California the largest single funder of
embryonic and pluripotent
stem cell research in the world and consequently one of the strongest job markets for regenerative
research.
In its white paper on
stem cell research published last Thursday, the DFG's senate confirmed its position that the use of adult
stem cells has to have priority
over embryonic stem cells.
Australian researchers have so far generated
over 50
embryonic stem cell lines from surplus embryos, and three
research groups have been licensed to attempt somatic
cell nuclear transfer.
If dealing with the public relations nightmare
over its on - off - on funding of Planned Parenthood wasn't enough, the Susan G. Komen for the Cure cancer charity last week also got entangled, somewhat bizarrely, in the debate
over human
embryonic stem (ES)
cell research.
In a Senate hearing today on the ongoing legal tussle
over human
embryonic stem cell (hESC)
research, lawmakers and expert witnesses lamented the disruption to this promising
research.
The two researchers analyzed nationally representative surveys collected between 2002 and 2010 with the goal of better understanding how the U.S. public came to form opinions in the debate
over human
embryonic stem cell research.
A noted U.S. fertility researcher is relocating to England in a move that some researchers say underscores the uncertainty created by the current debate
over government funding of
research involving
embryonic stem cells (Science, 13 July, p. 186).
February 2010 - Italian
stem cell scientists challenge goverment EuroSyStem scientist Elena Cattaneo challenges Italian government - the story continues In the summer of 2009, three Italian
stem celli scientists unsuccessfully challenged their government in the courts
over its decision to exclude human
embryonic stem cell research from a ministerial funding call for projects on
stem cell biology.
That study found that since MSCRF first began awarding grants in 2007, its pattern of giving shifted
over the years from strongly favoring projects focusing on ethically contentious human
embryonic stem cell research (hESCR) to projects focusing on ethically non-contentious adult
stem cells and other non-
embryonic stem cell research.
But for well
over a decade now, ethically contentious human
embryonic stem cell research (hESCR) has notably failed to live up to all its hype, with promises of miracle cures within «five to 10 years» remaining unfulfilled.
Collins warned of a «cloud hanging
over this field,» of top US scientists potentially being driven into other disciplines or other countries, and of «severe collateral damage» to the burgeoning field of induced pluripotent
stem cell research, which, he argued, relies on human
embryonic stem cells as a «gold standard» comparator.
The mouse lines, which will be stored in the form of frozen embryos, frozen sperm and frozen
embryonic stem (ES)
cells, will be delivered to NIH - funded mouse repositories that supply mice to universities, medical schools and
research labs all
over the world.
Proponents of destructive human
embryonic stem cell research have all too often been quick to dismiss ethical concerns
over the commodification and destruction of human life, concerns, they say, that represent an obstacle to the pursuit of science.
David Volk of the South Dakotans for Lifesaving Cures said the initiative will ask voters to allow
research on
embryonic stem cells, but only
stem cells left
over from in vitro fertilization procedures,
cells that would have been discarded otherwise.
The Institute's website notes the need for its work, pointing out that there are
over 300 nonprofit
research foundations and academic centers expressly devoted to
research using
embryonic stem cells.
The discovery, by scientists at Kyoto University and the University of Wisconsin - Madison, seemed to promise a way out of the bitter debates
over embryonic -
stem -
cell research: rather than using human embryos as a source of
stem cells, produce them from adult
cells.
Without these two technologies that you'll hear about in a moment, there would be no such thing as human
embryonic stem cell research, and President Bush could have enjoyed his summer vacation in Crawford without having to agonize
over the baptism of the infamous 64
stem cell lines.
And theres even better news: By using the patients own
stem cells, the surgical team avoids the ethical debate
over using
embryonic tissue for
research purposes.